Schedule 13G ownership disclosure

ASPIRE BIOPHARMA HLDGS INC

Common Stock · CUSIP: 738920107

Event date: 2025-02-17

Filing-level shares
4,883,375.00
Percent of class
9.98%
  • Lance Friedman

    Shares: 4,883,375.00 · Class: 9.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-008412
Form type
SCHEDULE 13G
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
Feb 26, 2025
Reporting period
Feb 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub